Literature DB >> 18248664

Age-related reduction in retinal deimination levels in the F344BN rat.

Sanjoy K Bhattacharya1, Brent Sinicrope, Mary E Rayborn, Joe G Hollyfield, Vera L Bonilha.   

Abstract

Increased deimination and peptidyl arginine deiminase type 2 (PAD2) expression has been observed in age-related neurodegenerative diseases without discrimination between their aging and disease component. Here, we describe reduced levels of deimination commensurate with reduced protein, mRNA and activity of peptidylarginine deiminase type 2 in the retina, optic nerve and plasma of aged rats when compared to young rats. The decrease was significant in the ganglion cell layer, inner plexiform layer and inner nuclear layer. Because our observations suggest reduced deimination is a consequence of aging, we conclude that increased deimination must be a consequence of disease. Our findings are important to understand late-onset and progressive diseases such as glaucoma, pseudoexfoliation syndrome, age-related macular degeneration and Oguchi's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248664      PMCID: PMC2722784          DOI: 10.1111/j.1474-9726.2008.00376.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  19 in total

1.  Neuronal MAP2 mRNA: species-dependent differential dendritic targeting competence.

Authors:  Massimiliano Cristofanilli; Solon Thanos; Jürgen Brosius; Stefan Kindler; Henri Tiedge
Journal:  J Mol Biol       Date:  2004-08-20       Impact factor: 5.469

Review 2.  Protein modification in aging.

Authors:  E R Stadtman
Journal:  J Gerontol       Date:  1988-09

3.  Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues.

Authors:  K Watanabe; K Akiyama; K Hikichi; R Ohtsuka; A Okuyama; T Senshu
Journal:  Biochim Biophys Acta       Date:  1988-09-08

4.  Arginine deiminases: therapeutic tools in the etiology and pathogenesis of Alzheimer's disease.

Authors:  Cassandra Louw; Alon Gordon; Nicolette Johnston; Carolyn Mollatt; Graeme Bradley; Chris G Whiteley
Journal:  J Enzyme Inhib Med Chem       Date:  2007-02       Impact factor: 5.051

5.  Immunocytochemical localization of microtubule-associated proteins 1A and 2 in the rat retina.

Authors:  S Okabe; Y Shiomura; N Hirokawa
Journal:  Brain Res       Date:  1989-04-03       Impact factor: 3.252

6.  Thy-1 antigen: a ganglion cell specific marker in rodent retina.

Authors:  C J Barnstable; U C Dräger
Journal:  Neuroscience       Date:  1984-04       Impact factor: 3.590

7.  Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration.

Authors:  H Asaga; A Ishigami
Journal:  Neurosci Lett       Date:  2001-02-16       Impact factor: 3.046

Review 8.  Autoantibodies as predictors of disease.

Authors:  R Hal Scofield
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

Review 9.  PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease.

Authors:  Erik R Vossenaar; Albert J W Zendman; Walther J van Venrooij; Ger J M Pruijn
Journal:  Bioessays       Date:  2003-11       Impact factor: 4.345

10.  Human PAD4 regulates histone arginine methylation levels via demethylimination.

Authors:  Yanming Wang; Joanna Wysocka; Joyce Sayegh; Young-Ho Lee; Julie R Perlin; Lauriebeth Leonelli; Lakshmi S Sonbuchner; Charles H McDonald; Richard G Cook; Yali Dou; Robert G Roeder; Steven Clarke; Michael R Stallcup; C David Allis; Scott A Coonrod
Journal:  Science       Date:  2004-09-02       Impact factor: 47.728

View more
  8 in total

1.  The Role of Deimination in Regenerative Reprogramming of Neurons.

Authors:  Di Ding; Mabel Enriquez-Algeciras; Anddre Osmar Valdivia; Juan Torres; Cameron Pole; John W Thompson; Tsung-Han Chou; Miguel Perez-Pinzon; Vittorio Porciatti; Susan Udin; Eric Nestler; Sanjoy K Bhattacharya
Journal:  Mol Neurobiol       Date:  2018-07-26       Impact factor: 5.590

2.  Deimination restores inner retinal visual function in murine demyelinating disease.

Authors:  Mabel Enriquez-Algeciras; Di Ding; Fabrizio G Mastronardi; Robert E Marc; Vittorio Porciatti; Sanjoy K Bhattacharya
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

3.  Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).

Authors:  Vera L Bonilha; Karen G Shadrach; Mary E Rayborn; Yong Li; Gayle J T Pauer; Stephanie A Hagstrom; Sanjoy K Bhattacharya; Joe G Hollyfield
Journal:  Exp Eye Res       Date:  2013-04-03       Impact factor: 3.467

Review 4.  The Relationship of the Mechanisms of the Pathogenesis of Multiple Sclerosis and the Expression of Endogenous Retroviruses.

Authors:  Vera R Lezhnyova; Ekaterina V Martynova; Timur I Khaiboullin; Richard A Urbanowicz; Svetlana F Khaiboullina; Albert A Rizvanov
Journal:  Biology (Basel)       Date:  2020-12-11

5.  Lyso-Lipid-Induced Oligodendrocyte Maturation Underlies Restoration of Optic Nerve Function.

Authors:  Anddre Osmar Valdivia; Sanjoy K Bhattacharya
Journal:  eNeuro       Date:  2022-01-26

6.  ROS-induced PADI2 downregulation accelerates cellular senescence via the stimulation of SASP production and NFκB activation.

Authors:  Hyun-Jung Kim; Woo-Jin Kim; Hye-Rim Shin; Hee-In Yoon; Jae-I Moon; Eunji Lee; Jin-Muk Lim; Young-Dan Cho; Mi-Hye Lee; Hong-Gee Kim; Hyun-Mo Ryoo
Journal:  Cell Mol Life Sci       Date:  2022-02-26       Impact factor: 9.207

7.  Murine Retinal Citrullination Declines With Age and is Mainly Dependent on Peptidyl Arginine Deiminase 4 (PAD4).

Authors:  T J Hollingsworth; Marko Z Radic; Sarka Beranova-Giorgianni; Francesco Giorgianni; Yanming Wang; Alessandro Iannaccone
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

8.  In vivo expression of peptidylarginine deiminase in Drosophila melanogaster.

Authors:  Olena Mahneva; Monica G Risley; Ciny John; Sarah L Milton; Ken Dawson-Scully; William W Ja
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.